港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

科伦博泰生物-B

503.500

+6.5001.31%

成交量：85.63万

成交额：4.28亿

市值：1,174.09亿

市盈率：-267.50

高：508.000

开：481.000

低：481.000

收：497.000

52周最高：581.000

52周最低：228.200

股本：2.33亿

香港流通股本：1.63亿

量比：1.26

换手率：0.53%

股息：- -

股息率：- -

每股收益(LYR):-1.882

净资产收益率：-9.34%

总资产收益率：-4.26%

市净率：21.23

市盈率(LYR):-267.50

市销率: 50.22

数据加载中...

总览公司新闻资讯公告

科倫博泰（06990）2025年12月股份变动月报表：股本维持稳定

每日卖空追踪 | 科伦博泰生物-B 01月05日卖空量成交6.59万股，卖空比例为6.68%

《股市简讯》中国科伦博泰生物一度大涨9.4%，联合疗法获突破性疗法认定

科伦博泰生物-B(06990.HK)一度涨超6%

每日经济新闻

科伦博泰生物-B(06990)核心产品TROP2 ADC芦康沙妥珠单抗(SAC-TMT)联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获NMPA突破性疗法认定

科伦博泰生物-B：Sac-TMT联合免疫疗法帕博利珠单抗获国家药监局突破性治疗药物认定

恒瑞、百济双雄挺进TOP20！翰森、博泰加速冲刺，11家中国药企入榜，药企市值TOP50大洗牌

科伦博泰生物-B(06990)：ITGB6 ADC SKB105新药临床试验申请获国家药品监督管理局批准

新版国家医保目录今日起实施科伦博泰生物-B（06990）三款创新药惠及患者

科伦博泰生物-B涨0.35% 股价突破400港元大关

每日卖空追踪 | 科伦博泰生物-B 12月30日卖空量成交2.35万股，卖空比例为5.51%

四川大力发展医药创新产业，政策组合拳效应已逐渐显现！

医药生物行业周报：2026年为IO联合ADC大年有哪些关键催化？

智通港股通占比异动统计|12月26日

科伦博泰生物-B12月24日获主力加仓382.8万元

【兴证医药】医药生物行业2026年年度策略：创新迈入新篇章，国际化驶向新征程

兴证医药健康

【券商聚焦】国泰海通：siRNA药物进入快速发展期

每日卖空追踪 | 科伦博泰生物-B 12月23日卖空量成交2.15万股，卖空比例为5.18%

科伦博泰生物-B12月23日主力净流入68.7万元散户资金抛售

HTI医药2025年12月第三周周报：行业高景气，持续关注创新药械产业链

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/06990/news?page=6"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":503.5,"timestamp":1775117301007,"preClose":497,"halted":0,"volume":856267,"delay":0,"changeRate":0.013078470824949699,"floatShares":162769979,"shares":233185969,"eps":-1.8822243170597912,"marketStatus":"已收盘","change":6.5,"latestTime":"04-02 16:08:21","open":481,"high":508,"low":481,"amount":427890983,"amplitude":0.054326,"askPrice":503.5,"askSize":12200,"bidPrice":502,"bidSize":1700,"shortable":3,"etf":0,"ttmEps":-1.8822243170597912,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":5,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":497,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.26347,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-4.26%","roe":"-9.34%","lyrEps":-1.882224,"volumeRatio":1.26347,"shares":233185969,"dividePrice":0,"high":508,"amplitude":0.054326,"preClose":497,"low":481,"week52Low":228.2,"pbRate":"21.23","psRate":"50.22","week52High":581,"institutionHeld":0,"latestPrice":503.5,"committee":-0.755396,"eps":-1.8822243170597912,"divideRate":0,"volume":856267,"delay":0,"ttmEps":-1.8822243170597912,"open":481,"prevYearClose":392.2,"prevWeekClose":457.6,"prevMonthClose":460,"prevQuarterClose":460,"fiveDayClose":427.4,"twentyDayClose":369.8,"sixtyDayClose":432},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盘后","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.6316,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1774540800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-04-01","current":-267.502654,"percent":0.060921,"low":-351.800852,"twenty":-172.20913,"median":-125.040793,"eighty":-50.917117,"high":-21.029201,"avg":-127.409086,"sd":77.323333,"marketCap":115893442000},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-01","current":-266.039517,"twenty":-172.20913,"median":-125.040793,"eighty":-50.917117,"marketCap":115893442000}],"updateTime":1775118614552},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1139635977","title":"科倫博泰（06990）2025年12月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139635977","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139635977?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 16:57","pubTimestamp":1767603476,"startTime":"0","endTime":"0","summary":"四川科倫博泰生物醫藥股份有限公司（简称“科倫博泰”，股票代码：06990）于2026年1月5日披露2025年12月股份变动月报表。报告期内，公司注册股本合计为人民币233,185,969元，H股、内资股及非上市外资股的已发行股份数分别维持在162,769,979股、65,773,800股和4,642,190股，均与上月持平。\n根据公告，公司本月内无新增发行、回购或注销活动，整体股本结构保持稳定，亦无股份期权或股权激励计划的授出、行使或失效。公司同时确认所有相关发行及股份事宜均遵守香港联合交易所有限公司《上市规则》及其他适用法律法规。\n公告由联席公司秘书周泽剑签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601889317","title":"每日卖空追踪 | 科伦博泰生物-B 01月05日卖空量成交6.59万股，卖空比例为6.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601889317","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601889317?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 16:30","pubTimestamp":1767601837,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间01月05日，涨7.84%，卖空量成交6.59万股，较上一交易日增加58.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163743a49e2bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163743a49e2bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601507714","title":"《股市简讯》中国科伦博泰生物一度大涨9.4%，联合疗法获突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2601507714","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601507714?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 13:25","pubTimestamp":1767590711,"startTime":"0","endTime":"0","summary":"《股市简讯》中国科伦博泰生物一度大涨9.4%，联合疗法获突破性疗法认定* 中国生物科技公司--科伦博泰生物6990.HK周一盘中一度劲升9.4%。* 该公司此前公告称，SKB105的新药临床试验申请已获中国国家药品监督管理局药品审评中心批准，用于治疗晚期实体瘤；核心产品芦康沙妥珠单抗联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获国家药监局突破性疗法认定。* 恒生生物科技指数.HSBIO盘中最多上扬4.6%。（完）更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文；审校 张喜良) ((kaiwen.xu@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nL4T3Y60AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601071680","title":"科伦博泰生物-B(06990.HK)一度涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601071680","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601071680?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 11:04","pubTimestamp":1767582277,"startTime":"0","endTime":"0","summary":"每经AI快讯，科伦博泰生物-B(06990.HK)一度涨超6%，截至发稿涨5.89%，报427.2港元，成交额1.29亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608569551.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608569551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601020061","title":"科伦博泰生物-B(06990)核心产品TROP2 ADC芦康沙妥珠单抗(SAC-TMT)联合免疫疗法帕博利珠单抗一线治疗PD-L1阳性局部晚期或转移性非小细胞肺癌获NMPA突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2601020061","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601020061?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 08:01","pubTimestamp":1767571299,"startTime":"0","endTime":"0","summary":"此前，公司公布了芦康沙妥珠单抗联合帕博利珠单抗一线治疗PD-L1阳性NSCLC的3期OptiTROP-Lung05临床试验结果，其在主要终点无进展生存期显示出统计学意义和临床意义的显著改善，并在总生存期方面观察到获益趋势。OptiTROP-Lung05研究是首个免疫联合ADC在一线治疗NSCLC上达到主要终点的3期临床研究。此次在一线治疗PD-L1阳性NSCLC获得突破性疗法认定，将为加速芦康沙妥珠单抗在此适应症审评与上市进程提供助力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","BK4023","LU1169590202.USD","LU0196878994.USD","BK4231","BK1161","06990","PD","BK4080","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197028053","title":"科伦博泰生物-B：Sac-TMT联合免疫疗法帕博利珠单抗获国家药监局突破性治疗药物认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1197028053","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197028053?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 07:45","pubTimestamp":1767570337,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B（股票代码：06990）近日宣布，其核心候选药物Sac-TMT与免疫治疗药物帕博利珠单抗（Pembrolizumab）的联合疗法，已正式获得中国国家药品监督管理局（NMPA）授予的突破性治疗药物认定。\n这一认定标志着该联合疗法在特定适应症的临床开发进程中取得重要进展，有望为患者提供新的治疗选择。突破性治疗药物认定旨在加速具有突出临床优势的创新药物的审评审批流程。\nSac-TMT是科伦博泰生物-B自主研发的一款创新生物药，与帕博利珠单抗的联合应用展示了协同增效的潜力。此次获得认定，不仅是对该疗法临床价值的认可，也体现了公司在肿瘤创新药研发领域的实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","06990","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601029158","title":"恒瑞、百济双雄挺进TOP20！翰森、博泰加速冲刺，11家中国药企入榜，药企市值TOP50大洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2601029158","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601029158?lang=zh_cn&edition=fundamental","pubTime":"2026-01-04 21:09","pubTimestamp":1767532195,"startTime":"0","endTime":"0","summary":"2025年的全球药企市值TOP50榜单，不再是跨国巨头的独角戏，11家中国药企集体亮剑。从“还差临门一脚”到稳坐TOP20一隅如果将时间拨回到2023年，中国药企在全球市值TOP50中的处境，常被形容为还差“临门一脚”。而到了2025年末，中国药企在全球药企市值的排行已经发生了实质性改变。恒瑞在2025年中登陆港交所后，其在港股市值一度突破5000亿港元。首次冲进全球制药企业市值TOP20的百济，则代表着另一条路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104212120a6f20aa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01801","BK1161","LU0196878994.USD","BK1583","06990","09926","03692","BK1589","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600040163","title":"科伦博泰生物-B(06990)：ITGB6 ADC SKB105新药临床试验申请获国家药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2600040163","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600040163?lang=zh_cn&edition=fundamental","pubTime":"2026-01-04 19:59","pubTimestamp":1767527952,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，公司自主研发的靶向整合素β6抗体偶联药物SKB105的新药临床试验申请已获中国国家药品监督管理局药品审评中心批准，用于治疗晚期实体瘤。公司计划于近期向中国国家药品监督管理局药品审评中心递交SKB118/CR-001的IND申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","BK4231","ADC","06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600100700","title":"新版国家医保目录今日起实施 科伦博泰生物-B（06990）三款创新药惠及患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2600100700","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600100700?lang=zh_cn&edition=fundamental","pubTime":"2026-01-01 09:03","pubTimestamp":1767229415,"startTime":"0","endTime":"0","summary":"在这份新目录中，科伦博泰生物-B自主研发的芦康沙妥珠单抗(佳泰莱)、西妥昔单抗N01(达泰莱)与塔戈利单抗(科泰莱)三款创新药物成功跻身其中。据悉，对于晚期三阴性乳腺癌患者及EGFR-TKI治疗失败的非小细胞肺癌患者而言，传统治疗手段往往收效甚微。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06978","06990","159992","BK1574","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595414777","title":"科伦博泰生物-B涨0.35% 股价突破400港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2595414777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595414777?lang=zh_cn&edition=fundamental","pubTime":"2025-12-31 09:30","pubTimestamp":1767144618,"startTime":"0","endTime":"0","summary":"2025年12月31日早盘09时30分，科伦博泰生物-B股票出现波动，股价快速上涨0.35%。截至发稿，该股报400.600港元/股，成交量100股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出20.01万港元。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.55%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123109301897a0e0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025123109301897a0e0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595715952","title":"每日卖空追踪 | 科伦博泰生物-B 12月30日卖空量成交2.35万股，卖空比例为5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595715952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595715952?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 16:30","pubTimestamp":1767083437,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月30日，跌1.63%，卖空量成交2.35万股，较上一交易日减少51.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163631a6e07fc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163631a6e07fc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595271598","title":"四川大力发展医药创新产业，政策组合拳效应已逐渐显现！","url":"https://stock-news.laohu8.com/highlight/detail?id=2595271598","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595271598?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 07:00","pubTimestamp":1767049238,"startTime":"0","endTime":"0","summary":"5月，四川省出台并实施了《四川省促进医药健康产业发展若干措施》。未来，随着政策组合拳效应的逐渐显现，从研发到应用全链条的打通，四川医药产业创新发展将迈上一个新阶段。近年来，四川省一直在积极制定推动创新药发展的相关政策，支持创新药技术攻关、生产制造、临床应用。未来，随着《四川省支持生物医药和医疗器械产业高质量发展若干政策措施》等新政策的不断落地执行，预计 2025 年底前医药健康产业营收将突破4000亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230070044a6de8bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230070044a6de8bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0196878994.USD","BK1574","06990","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594222048","title":"医药生物行业周报：2026年为IO联合ADC大年 有哪些关键催化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2594222048","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594222048?lang=zh_cn&edition=fundamental","pubTime":"2025-12-28 00:00","pubTimestamp":1766851200,"startTime":"0","endTime":"0","summary":"IO+ADC：26 年催化剂密集大年，中国主导二代IO 联合ADC 研发。1/TIGIT）进度靠前，已启动6 项联合ADC 的全球III 期。以中国biotech 为主导的PD-1/VEGF、PD-L1/VEGF 双抗联合ADC 已进入1/2 期研究，有望在2026 年读出1/2 期数据，有希望在2026-2027 年启动国际多中心3 期研究，在部分癌种确立为新的一线标准疗法。期间器械受脑机接口主题催化表现强势，原料药则部分标的受六氟磷酸锂涨价带动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228194634a4820582&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251228194634a4820582&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1161","IE00B543WZ88.USD","LU0348783233.USD","LU0348827113.USD","LU1720050803.USD","LU2399975544.HKD","BK1574","LU1794554557.SGD","LU2476274720.SGD","LU2488822045.USD","BK1583","LU0417516902.SGD","LU0348784397.USD","LU0348766576.USD","LU0417516738.SGD","LU0634319403.HKD","LU0348767384.USD","LU1961090484.USD","LU2778985437.USD","IE00BPRC5H50.USD","LU0348735423.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","LU2476274308.USD","LU0348825331.USD","LU0417516571.SGD","LU0561508036.HKD","06990","01877","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594252445","title":"智通港股通占比异动统计|12月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594252445?lang=zh_cn&edition=fundamental","pubTime":"2025-12-26 08:35","pubTimestamp":1766709358,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月24日披露数据，中通快递-Ｗ、MONGOLIAN MINING CORPORATION、信利国际港股通持股占比增加值最大，分别增加0.12%、0.05%、0.03%；美图公司、恒生科技ETF、顺丰同城港股通持股占比减少值最大，分别减少-0.12%、-0.01%、-0.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385933.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01357","01709","01798","03323","01635","01800","06166","00638","00553","02429","00699","00496","02465","02160","02579","02402","06990","01952","00178","09699","01528","00839","02603","01072","02562","00038","01828","01257","00120","00732","01341","01783","01776","01606","02800","06693","02570","00816","03032","02498","01896","00175","06099","00035","02328","00775","06865","00001","00568"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2594228218","title":"科伦博泰生物-B12月24日获主力加仓382.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594228218","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594228218?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 16:15","pubTimestamp":1766564141,"startTime":"0","endTime":"0","summary":"12月24日, 科伦博泰生物-B股价涨0.19%，报收419.20元，成交金额8980.8万元，换手率0.13%，振幅3.25%，量比0.54。科伦博泰生物-B今日主力资金净流入382.8万元，上一交易日主力净流入68.7万元。该股近5个交易日上涨3.10%，主力资金累计净流入1338.2万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9555.0万元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161911a6c97283&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161911a6c97283&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593779374","title":"【兴证医药】医药生物行业2026年年度策略：创新迈入新篇章，国际化驶向新征程","url":"https://stock-news.laohu8.com/highlight/detail?id=2593779374","media":"兴证医药健康","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593779374?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 14:51","pubTimestamp":1766559113,"startTime":"0","endTime":"0","summary":"兴业证券医药小组近期，我们发布了《医药生物行业2026年年度策略：创新迈入新篇章，国际化驶向新征程》，欢迎阅读^^投资要点：“创新+国际化”仍将是2026年板块核心主线。重点关注创新药产业链，景气度预计将持续向上。同时，医疗器械行业阶段性影响因素持续缓和，创新与国际化加速推进，2026年有望迎来改善。中国创新药在新靶点、新技术、新疾病领域的布局已经呈现领先趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224151317a6c92a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224151317a6c92a6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","LU0417516902.SGD","IE00BPRC5H50.USD","IE00B543WZ88.USD","01530","02268","LU2488822045.USD","09926","LU0348825331.USD","09939","01801","BK1574","06990","LU0348767384.USD","LU2476274720.SGD","LU2778985437.USD","BK1161","LU0348766576.USD","LU0634319403.HKD","LU0417516738.SGD","LU1720050803.USD","LU0348827113.USD","IE00B5MMRT66.SGD","LU0348783233.USD","LU0417516571.SGD","LU2476274308.USD","LU0540923850.HKD","LU1961090484.USD","LU2399975544.HKD","LU0561508036.HKD","LU1794554557.SGD","ONC","02615","BK1515","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593044263","title":"【券商聚焦】国泰海通：siRNA药物进入快速发展期","url":"https://stock-news.laohu8.com/highlight/detail?id=2593044263","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593044263?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 09:00","pubTimestamp":1766538027,"startTime":"0","endTime":"0","summary":"小核酸药物的种类多样，其中siRNA药物的安全性和长效性更好，已成为国内药企的开发重点。自2016年起，随着GalNac递送系统的升级和完全修饰的应用，siRNA药物进入快速发展期，在罕见病领域验证其价值，目前逐步进入了常见病的研发兑现阶段，在心血管疾病、慢乙肝、减重、抗凝、自免等大适应症均可能会有“大药”的诞生。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972139","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU1794554557.SGD","LU0348766576.USD","LU2125910500.SGD","BK0012","01801","BK1141","06990","BK1589","LU2488822045.USD","LU1303224171.USD","LU1046422090.SGD","LU1023057109.AUD","BK0184","BK1147","BK1191","LU0348825331.USD","BK1564","02359","01276","LU2097828631.EUR","IE00B543WZ88.USD","LU1720050803.USD","LU0320764599.SGD","LU1770034418.SGD","02611","BK0276","LU2097828474.EUR","LU2476274720.SGD","09926","LU0502904849.HKD","LU0348735423.USD","LU0561508036.HKD","LU1961090484.USD","06160","LU0348783233.USD","LU2399975544.HKD","LU0634319403.HKD","BK1574","LU1719994722.HKD","LU0348784397.USD","601211","BK1576","LU0588546209.SGD","LU0348767384.USD","LU2097828805.USD","LU0417516571.SGD","LU1969619763.USD","BK1583","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593446611","title":"每日卖空追踪 | 科伦博泰生物-B 12月23日卖空量成交2.15万股，卖空比例为5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446611?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 16:30","pubTimestamp":1766478638,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间12月23日，涨1.31%，卖空量成交2.15万股，较上一交易日减少69.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163604a6c52043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163604a6c52043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593446620","title":"科伦博泰生物-B12月23日主力净流入68.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593446620","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593446620?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 16:15","pubTimestamp":1766477730,"startTime":"0","endTime":"0","summary":"12月23日, 科伦博泰生物-B股价涨1.31%，报收418.40元，成交金额1.7亿元，换手率0.25%，振幅6.54%，量比0.96。科伦博泰生物-B今日主力资金净流入68.7万元，上一交易日主力净流出351.5万元。该股近5个交易日上涨3.96%，主力资金累计净流入584.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入9442.5万元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161737a6c50a10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161737a6c50a10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593494070","title":"HTI医药2025年12月第三周周报：行业高景气，持续关注创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494070","media":"海通国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593494070?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 16:07","pubTimestamp":1766477237,"startTime":"0","endTime":"0","summary":"2025年12月第三周A股医药板块表现与大盘相当。2025年12月第三周上证综指上涨0.03%，SW医药生物下跌0.1%，涨跌幅在申万一级行业中排名第19位。截至2025年12月19日，医药板块相对于全部A股的溢价水平目前处于正常水平，当前相对溢价率70.1%。2025年12月第三周美股标普医疗保健精选行业+0.6%，同期标普500+0.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","09606","02269","02487","06990","06160","06078","02359","HK0000252152.HKD","01801","BK1515","01858","BK1161","01276","BK1574","HK0000252160.HKD","09939","LU2543165471.USD","01530","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}